Company Of The Day: Merck

+5.33%
Upside
93.99
Market
99.00
Trefis
MRK: Merck logo
MRK
Merck

What?

Merck (NYSE:MRK) posted a stronger than expected set of Q3 2021 results, with revenue rising by about 20% year-over-year to $13.15 billion and adjusted EPS rising 28% to $1.75. The company also raised its full-year revenue guidance to between $47.4 billion and $47.9 billion.

Why?

Relevant Articles
  1. Will Merck Stock Rise After Its Q1 Results?
  2. Company Of The Day: Merck
  3. What’s Next For Merck Stock After A 6% Fall In A Month?
  4. Will Merck Stock Rise After Its Q4 Results?
  5. Here’s A Better Pharmaceutical Pick Over Merck Stock
  6. What’s Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?

Growth was driven by strong demand for drugs including Keytruda, Gardasil, and animal health products.

So What?

Merck stock gained almost 6% in Thursday’s trading.

See Our Complete Analysis For Merck

What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since 2016.

Invest with Trefis Market Beating Portfolios
See all Trefis Price Estimates